
《中華經典古籍庫》 是大型古籍整理本數據庫,該數據庫現已改版升級,收錄資源涵蓋經史子集各部,提供多維度的檢索功能和多元化的閱讀方式,歡迎使用!
注意: 現時圖書館已訂購所有期數「第一至第十二期」,讀者可閱讀所有篇章的全文。
? 資料庫連結: https://rb.gy/ofkdxv

《中華經典古籍庫》 是大型古籍整理本數據庫,該數據庫現已改版升級,收錄資源涵蓋經史子集各部,提供多維度的檢索功能和多元化的閱讀方式,歡迎使用!
注意: 現時圖書館已訂購所有期數「第一至第十二期」,讀者可閱讀所有篇章的全文。
? 資料庫連結: https://rb.gy/ofkdxv

Consensus is an AI academic search engine grounded in scientific research that can summarize peer-reviewed literature with real citations. Consensus uses natural language processing techniques to help you quickly understand key information from the research literature and streamline your literature review process.
Use it to enhance your research now!
Please note: Users are required to create an account with Shue Yan webmail to log in Consensus.
Access link: https://consensus.app/

Scite is an AI-powered platform that helps you better discover and evaluate scientific articles regarding how they support or contradict the cited work. In addition to providing context on citations through Smart Citations, Scite also allows you to search the metadata of scholarly sources, manage article collections, and utilize an AI Assistant for generating ideas and improving your writing quality.
Please note: Users are required to create an account with Shue Yan webmail to access features, including Notifications, Assistant History, and Dashboards. Access link: https://rb.gy/nz4shf

DDC國際博碩士論文全文資料庫 (Digital Dissertation Consortium) 現已開放試用。
該資料庫平台現已完成全面升級,提供全新的操作介面、串接 PQDT (ProQuest Dissertations and Theses) 推薦論文系統及多項功能,提供多種語言全文論文,涵蓋各學科領域。對於學位論文的撰寫,及研究文獻資料的蒐集,有所裨益。
*使用須知:在試用期間,使用者每篇論文文章僅能閱讀5頁。
試用期於2025年4月30日結束。歡迎試用!
資料庫連結: https://rb.gy/w2w1ac

Explore the World Dissertation Library (WDL) on Trial!
It is a top-notch scholarly database for dissertations, theses, and academic papers. With over 2,000 educational institutions from more than 150 countries and regions, it offers exceptional information services to educators, researchers, and students in various disciplines, such as technology, social sciences, economics, management science, and more.
WDL is now available for a trial period until 30 Apr 2025.
Access link: https://bit.ly/3DXiCh1